CLINICAL_TRIALS
trial_result
· 2014-06-18
Clinical Trial Update: A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid Tumors [Phase 2]
Summary
Phase 2 trial update for ramucirumab with paclitaxel in malignant solid tumors completed with posted results in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Malignant Solid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2014-06-18